These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21847650)

  • 1. Gut mucosal permeability, β1 receptor blockers and gastric tonometry: the time is now!
    Gutierrez G; Ballarino G
    Intensive Care Med; 2011 Nov; 37(11):1721-2. PubMed ID: 21847650
    [No Abstract]   [Full Text] [Related]  

  • 2. Beta-1 blocker improves survival of septic rats through preservation of gut barrier function.
    Mori K; Morisaki H; Yajima S; Suzuki T; Ishikawa A; Nakamura N; Innami Y; Takeda J
    Intensive Care Med; 2011 Nov; 37(11):1849-56. PubMed ID: 21847651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decatecholaminisation during sepsis.
    Rudiger A; Singer M
    Crit Care; 2016 Oct; 20(1):309. PubMed ID: 27716402
    [No Abstract]   [Full Text] [Related]  

  • 4. Sepsis, ghrelin, the cholinergic anti-inflammatory pathway, gut mucosal hyperpermeability, and high-mobility group box 1.
    Fink MP
    Crit Care Med; 2009 Aug; 37(8):2483-5. PubMed ID: 19609124
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-1 blocker reduces inflammation and preserves intestinal barrier function after open abdominal surgery.
    Tan S; Zhou F; Zhang Z; Wang J; Xu J; Zhuang Q; Meng Q; Xi Q; Jiang Y; Wu G
    Surgery; 2021 Apr; 169(4):885-893. PubMed ID: 33303271
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats.
    Wu R; Dong W; Qiang X; Wang H; Blau SA; Ravikumar TS; Wang P
    Crit Care Med; 2009 Aug; 37(8):2421-6. PubMed ID: 19531942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-1 blockade in sepsis: what to expect?
    Enkhbaatar P
    Crit Care Med; 2013 Sep; 41(9):2237. PubMed ID: 23979375
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of vasoactive drugs on crystalloid fluid kinetics in septic sheep.
    Li Y; Xiaozhu Z; Guomei R; Qiannan D; Hahn RG
    PLoS One; 2017; 12(2):e0172361. PubMed ID: 28231305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta-blockade during sepsis: inspired or insane?
    Meldrum DR
    Crit Care Med; 2005 Oct; 33(10):2433-4. PubMed ID: 16215413
    [No Abstract]   [Full Text] [Related]  

  • 10. Esmolol for tight heart rate control in patients with STEMI: Design and rationale of the beta-blocker in acute myocardial infarction (BEAT-AMI) trial.
    Er F; Erdmann E; Nia AM; Dahlem KM; Biesenbach E; Herrfurth T; Taghiyev Z; Le MT; Hellmich M; Kuhr K; Caglayan E; Gassanov N
    Int J Cardiol; 2015; 190():351-2. PubMed ID: 25939126
    [No Abstract]   [Full Text] [Related]  

  • 11. Left Ventricle Function During Therapeutic Hypothermia with Beta
    Bergan HA; Halvorsen PS; Espinoza A; Kerans V; Skulstad H; Fosse E; Bugge JF
    Ther Hypothermia Temp Manag; 2018 Sep; 8(3):156-164. PubMed ID: 29394143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shen-Fu Decoction could ameliorate intestinal permeability by regulating the intestinal expression of tight junction proteins and p-VASP in septic rats.
    Liu F; Liu J; Liu Y; Zhang Y; Ding X
    J Ethnopharmacol; 2021 Mar; 268():113562. PubMed ID: 33217519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Esmolol reduces apoptosis and inflammation in early sepsis rats with abdominal infection.
    Lu Y; Yang Y; He X; Dong S; Wang W; Wang D; Zhang P
    Am J Emerg Med; 2017 Oct; 35(10):1480-1484. PubMed ID: 28457762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the β-Adrenergic Receptor Antagonists Landiolol and Esmolol: Receptor Selectivity, Partial Agonism, and Pharmacochaperoning Actions.
    Nasrollahi-Shirazi S; Sucic S; Yang Q; Freissmuth M; Nanoff C
    J Pharmacol Exp Ther; 2016 Oct; 359(1):73-81. PubMed ID: 27451411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infusion of esmolol attenuates lipopolysaccharide-induced myocardial dysfunction.
    Wang Z; Wu Q; Nie X; Guo J; Yang C
    J Surg Res; 2016 Jan; 200(1):283-9. PubMed ID: 26316443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytokine and radical inhibition in septic intestinal barrier failure.
    Schulz K; Sommer O; Jargon D; Utzolino S; Clement HW; Strate T; von Dobschuetz E
    J Surg Res; 2015 Feb; 193(2):831-40. PubMed ID: 25277359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imipenem and normal saline with cyclophosphamide have positive effects on the intestinal barrier in rats with sepsis.
    Yang J; Zhang S; Wu J; Zhang J; Dong J; Guo P; Tang S; Zhang W; Wu F
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2018 Jun; 162(2):90-98. PubMed ID: 29935492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ACP Journal Club. Review: in patients with heart failure, β-blockers reduce mortality but do not differ from each other.
    Khazanie P; Newby LK
    Ann Intern Med; 2013 May; 158(10):JC2-3. PubMed ID: 23689781
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic synergy and complementarity for ischemia/reperfusion injury: β1-adrenergic blockade and phosphodiesterase-3 inhibition.
    Huang MH; Poh KK; Tan HC; Welt FG; Lui CY
    Int J Cardiol; 2016 Jul; 214():374-80. PubMed ID: 27085132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of sepsis-induced inflammatory response by β1-adrenergic antagonists.
    Ibrahim-Zada I; Rhee P; Gomez CT; Weller J; Friese RS
    J Trauma Acute Care Surg; 2014 Feb; 76(2):320-7; discussion 327-8. PubMed ID: 24458040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.